Filing Details
- Accession Number:
- 0001826667-25-000057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-21 17:30:33
- Reporting Period:
- 2025-05-19
- Filing Date:
- 2025-05-21
- Accepted Time:
- 2025-05-21 17:30:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1826667 | Trisalus Life Sciences Inc. | TLSI | Surgical & Medical Instruments & Apparatus (3841) | 853009869 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1982638 | Richard Marshak | 6272 W. 91St Avenue Westminster CO 80031 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-19 | 21,428 | $5.18 | 75,698 | No | 4 | A | Direct | |
Common Stock | Disposition | 2025-05-19 | 6,597 | $5.18 | 69,101 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- The granted RSUs vest immediately.
- The sale of the shares was to cover the tax liability associated with the granted RSUs.